Diagnostic Utility of Exome Sequencing Among Israeli Children With Kidney Failure

Ben-Moshe, Yishay; Shlomovitz, Omer; Atias-Varon, Danit; Haskin, Orly; Ben-Shalom, Efrat; Shasha Lavsky, Hadas; Volovelsky, Oded; Mane, Shrikant; Ben-Ruby, Dror; Chowers, Guy; Skorecki, Karl; Borovitz, Yael; Kagan, Maayan; Mor, Nofar; Khavkin, Yulia; Tzvi-Behr, Shimrit; Pollack, Shirley; Toder, Moran Plonsky; Geylis, Michael; Schnapp, Aviad; Becker-Cohen, Rachel; Weissman, Irith; Schreiber, Ruth; Davidovits, Miriam; Frishberg, Yaacov; Magen, Daniella; Barel, Ortal; Vivante, Asaf

doi:10.1016/j.ekir.2023.07.019

Search citation statements

Order By: Relevance

Paper Sections

Select...

Donor Genetic Evaluation and Risk1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article4

Relationship

Self Cite0

Independent4

Authors

Journals

Cited by 4 publications

(1 citation statement)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A full discussion of genetic testing in living donors as well as recommendations for best practice was recently published 39 . The considerations for pediatric recipients are weighed differently than in adult recipients due to a notably higher incidence of genetic disease compared to adult patients (10%–20% in adults vs. 30%–45% in children with CKD) 40–43 …”

Section: Donor Genetic Evaluation and Riskmentioning

confidence: 99%

Strategies for choosing the best living donor: A review of the literature and a proposal of a decision‐making paradigm

Charnaya,

Van Arendonk,

Segev

2024

Pediatric Transplantation

View full text Add to dashboard Cite

Transplantation remains the gold‐standard treatment for pediatric end‐stage kidney disease. While living donor transplant is the preferred option for most pediatric patients, it is not the right choice for all. For those who have the option to choose between deceased donor and living donor transplantation, or from among multiple potential living donors, the transplant clinician must weigh multiple dynamic factors to identify the most optimal donor. This review will cover the key considerations when choosing between potential living donors and will propose a decision‐making algorithm.

show abstract

Section: Donor Genetic Evaluation and Riskmentioning

confidence: 99%